Evaluating the Risk of Metabolic Syndrome Based on an Artificial Intelligence Model

被引:13
作者
Chen, Hui [1 ]
Xiong, Shenghua [2 ]
Ren, Xuan [1 ]
机构
[1] Lanzhou Univ, Hosp 2, Dept Endocrinol, Lanzhou 730030, Peoples R China
[2] Lanzhou Univ, Sch Math & Stat, Lanzhou 730000, Gansu, Peoples R China
关键词
NEURAL-NETWORK; CARDIOVASCULAR-DISEASE; LOGISTIC-REGRESSION; INSULIN-RESISTANCE; CHOLESTEROL; PREVALENCE; COMPONENTS; ADULTS; PANEL;
D O I
10.1155/2014/207268
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
Metabolic syndrome is worldwide public health problem and is a serious threat to people's health and lives. Understanding the relationship between metabolic syndrome and the physical symptoms is a difficult and challenging task, and few studies have been performed in this field. It is important to classify adults who are at high risk of metabolic syndrome without having to use a biochemical index and, likewise, it is important to develop technology that has a high economic rate of return to simplify the complexity of this detection. In this paper, an artificial intelligence model was developed to identify adults at risk of metabolic syndrome based on physical signs; this artificial intelligence model achieved more powerful capacity for classification compared to the PCLR (principal component logistic regression) model. A case study was performed based on the physical signs data, without using a biochemical index, that was collected from the staff of Lanzhou Grid Company in Gansu province of China. The results show that the developed artificial intelligence model is an effective classification system for identifying individuals at high risk of metabolic syndrome.
引用
收藏
页数:12
相关论文
共 44 条
[1]   Using principal components for estimating logistic regression with high-dimensional multicollinear data [J].
Aguilera, AM ;
Escabias, M ;
Valderrama, MJ .
COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2006, 50 (08) :1905-1924
[2]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[3]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[4]  
2-S
[5]  
[Anonymous], ARTIFICIAL NEURAL NE
[6]  
Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO
[7]  
2-Y
[8]   Metabolic syndrome and the risk of cardiovascular disease in older adults [J].
Butler, J ;
Rodondi, N ;
Zhu, YW ;
Figaro, K ;
Fazio, S ;
Vaughan, DE ;
Satterfield, S ;
Newman, AB ;
Goodpaster, B ;
Bauer, DC ;
Holvoet, P ;
Harris, TB ;
de Rekeneire, N ;
Rubin, S ;
Ding, JZ ;
Kritchevsky, SB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) :1595-1602
[9]  
Leitao MPC, 2012, REV ASSOC MED BRAS, V58, P60, DOI 10.1016/S0104-4230(12)70156-2
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497